Organigram Holdings

OGI

Market cap $220M

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce that James Yamanaka, formerly Global Head of Strategy for British American Tobacco, has been appointed the Company's new Chief Executive Officer (CEO). Mr. Yamanaka is expected to assume the role effective on or about January 15, 2026. Mr. Yamanaka will also join the Company's board of di.

Organigram upgraded to Buy and Village Farms downgraded to Strong Sell, reflecting shifts in fundamentals and valuation. OGI stands out for its strong balance sheet, strategic partnership with BTI, and potential for margin expansion, despite near-term risks. VFF has surged 356% year-to-date, but concerns over its rapid run-up, lack of guidance, and potential Texas disappointment justify a cautious outlook.

Four cannabis stocks are demonstrating significant technical momentum, seemingly undeterred by new regulatory headwinds from Washington.

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), Canada's largest cannabis company by market share, today released new national polling figures, conducted on its behalf by Abacus Data showing that a clear majority of Canadians want Ottawa to modernize its approach to the legal cannabis sector. Nearly six in ten Canadians (59%) believe the federal government should do more to support jobs and innovation in the sector, while an equal number (59%) see the legal cannabis i.

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (“Organigram” or the “Company”) announces that Ms. Beena Goldenberg will extend her tenure as Chief Executive Officer until November 30, 2025 to support the completion of the Company's ongoing CEO search process. The Board's search has attracted strong interest and they are pleased with the progress as they focus on identifying a leader aligned with Organigram's strategic vision and growth objectives. Beena will continue to lead day-to-day operat.

The Canadian cannabis market continues to play a crucial role in the global marijuana industry. As U.S. legalization efforts gain traction, Canadian producers are positioning themselves for renewed growth and cross-border opportunities. The U.S. cannabis industry is projected to exceed $56 billion by 2030, supported by expanding state programs and rising consumer acceptance. Recently, discussions surrounding federal reclassification and potential legalization have fueled optimism across both Canadian and American markets. Consequently, many investors are closely watching leading Canadian stocks for potential breakouts. However, it is vital to remember that momentum can shift quickly in this volatile sector. Therefore, traders should focus on quality setups and confirm strength using technical analysis tools such as trendlines, volume indicators, and moving averages.

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), Canada's #1 cannabis company by market share, is pleased to announce the launch of happly, its third U.S. hemp-derived delta-9 brand, created specifically for the growing segment of consumers seeking ‘mindful recreation' with THC products. The launch of happly follows the Company's entry into the growing U.S. hemp-derived THC market with its lineup of Collective Project sparkling juices a.

Organigram Global Inc (NASDAQ: OGI) shares are trading sharply higher Monday afternoon, joining a rally across the cannabis sector.

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), Canada's largest cannabis company by market share, today released "High Impact, Green Growth: The Economic Footprint of Canada's Cannabis Industry," a national report done in partnership with the Business Data Lab at the Canadian Chamber of Commerce. The report, which examined figures for 2024, underscores the legal cannabis sector's role as a major driver of jobs, economic growth, and innovation, highlighting why it sho.

Organigram Global Inc. presents a unique value proposition through its disciplined approach of doubling down on the Canadian market and cautiously expanding its footprint globally. Margin headwinds witnessed in Q3 can be easily addressed through the increased harvesting capacity following optimizations and upgrades. Canadian LPs redirecting their cannabis to international markets allowed Organigram to become the market leader in terms of market share and widen its gap with its nearest competitor, Tilray.